Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Misoprostol in labor induction.

H Ozan1, G Uncu, V Yildirim

  • 1Department of Obstetrics and Gynaecology, Uludag University Medical Faculty, Bursa, Turkey.

The Journal of Obstetrics and Gynaecology Research
|May 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long term sexual outcomes of Mayer Rokitansky Küster Hauser Syndrome patients after Uncu-modified Davydov procedure.

Facts, views & vision in ObGyn·2023
Same author

Evaluation of cognitive deficits in patients infected with COVID-19.

European review for medical and pharmacological sciences·2022
Same author

A new COVID-19 prediction scoring model for in-hospital mortality: experiences from Turkey, single center retrospective cohort analysis.

European review for medical and pharmacological sciences·2020
Same author

Polidocanol (Lauromacrogol 400) has anti-angiogenic effects in vitro and in vivo.

European review for medical and pharmacological sciences·2016
Same author

Sedoanalgesia for cardioversion: comparison of alfentanil, remifentanil and fentanyl combined with propofol and midazolam: a prospective, randomized, double-blind study.

European review for medical and pharmacological sciences·2016
Same author

New probing and warm-wash-out technique improves early patency rates in arteriovenous fistula surgery.

European review for medical and pharmacological sciences·2015
Same journal

Elevated Body Mass Index Associated With Uterine Fibroids: A Retrospective Cohort Study With Bioinformatic Validation.

The journal of obstetrics and gynaecology research·2026
Same journal

Factors Affecting Quality of Life of Thai Cervical Cancer Patients.

The journal of obstetrics and gynaecology research·2026
Same journal

Association Between Serum Vitamin D Levels and Insulin Resistance in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

The journal of obstetrics and gynaecology research·2026
Same journal

Trends in Initial Cardiac Function, Treatment, and Outcomes in Peripartum Cardiomyopathy.

The journal of obstetrics and gynaecology research·2026
Same journal

Vaginal Microbiome and Preterm Birth in Pregnant Women From India.

The journal of obstetrics and gynaecology research·2026
Same journal

Maternal Severity and Diagnostic Validity of the Revised Japanese Criteria for Obstetric Disseminated Intravascular Coagulation: A Retrospective Observational Study.

The journal of obstetrics and gynaecology research·2026
See all related articles

This study shows that a new 50 microgram intravaginal misoprostol regimen is effective for labor induction. When combined with oxytocin if needed, it offers a safe option for inducing labor with minimal adverse effects.

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Pharmacology

Background:

  • Labor induction is a common obstetric procedure.
  • Misoprostol is a prostaglandin E1 analog used for cervical ripening and labor induction.
  • Optimizing misoprostol dosing regimens is crucial for efficacy and safety.

Purpose of the Study:

  • To evaluate the efficacy and safety of a new dosing regimen for intravaginal misoprostol in labor induction.
  • To determine the optimal dose and interval for misoprostol administration.
  • To assess the need for oxytocin augmentation with this regimen.

Main Methods:

  • A prospective study involving 58 patients undergoing labor induction.
  • Administered 50 microg of misoprostol intravaginally every 3 hours until adequate contractions were achieved.

Related Experiment Videos

  • Utilized oxytocin augmentation for inadequate contractions, with a maximum daily dose of 200 microg.

    • Main Results:

    • The mean required dose of misoprostol was 120.5 +/- 54.7 microg.
    • 10 out of 58 patients required oxytocin augmentation.
    • The mean labor induction to delivery time was 701.5 +/- 404.0 minutes.
    • Adverse events were minimal, including two cases of tachysystole and mild nausea/vomiting.

    Conclusions:

    • The 50 microg intravaginal misoprostol regimen, with oxytocin augmentation as needed, is an effective and safe method for labor induction.
    • This dosing strategy appears to balance efficacy with a low incidence of adverse events.
    • Further research may explore its use in diverse patient populations.